A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer
Top Cited Papers
- 26 February 2019
- journal article
- research article
- Published by Elsevier BV in European Urology
- Vol. 76 (1), 43-51
- https://doi.org/10.1016/j.eururo.2019.02.009
Abstract
No abstract availableKeywords
Funding Information
- Hybritech Inc
- European Association of Urology
This publication has 25 references indexed in Scilit:
- Quality-of-Life Effects of Prostate-Specific Antigen ScreeningNew England Journal of Medicine, 2012
- Prostate-Cancer Mortality at 11 Years of Follow-upNew England Journal of Medicine, 2012
- Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-upJNCI Journal of the National Cancer Institute, 2012
- Mortality Results from a Randomized Prostate-Cancer Screening TrialNew England Journal of Medicine, 2009
- Screening and Prostate-Cancer Mortality in a Randomized European StudyNew England Journal of Medicine, 2009
- Assessment of causes of death in a prostate cancer screening trialInternational Journal of Cancer, 2007
- Interval Cancers in Prostate Cancer Screening: Comparing 2- and 4-Year Screening Intervals in the European Randomized Study of Screening for Prostate Cancer, Gothenburg and RotterdamJNCI Journal of the National Cancer Institute, 2007
- Prostate cancer mortality reduction by screening: Power and time frame with complete enrollment in the European randomised screening for prostate cancer (ERSPC) trialInternational Journal of Cancer, 2001
- Interim analysis: The alpha spending function approachStatistics in Medicine, 1994
- Nonparametric Inference for a Family of Counting ProcessesThe Annals of Statistics, 1978